Skip to content
drillr.ai
Sign up

BLTE

Belite Bio, Inc

NASDAQ · Healthcare · Biotechnology · US

$193.61
+13.16%
Ask drillr
0
Insider buys (3m)
16
Insider sells (3m)
-$3.0M
Net value (3m)
+30.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 14, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale223$181
Aug 14, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale144$180
Aug 14, 2026Chuang Hao-Yuan · director, officer: Chief Financial OfficerSale223$181
Aug 14, 2026Lin Yu-Hsin · director, officer: Chief Executive OfficerSale142$180
Jun 22, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale1,199$146
Jun 22, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale4,861$145
Jun 22, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale3,748$145
Jun 22, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale96$144
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale2,054$138
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale1,035$145
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale1,897$144
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale450$142
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale100$142
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale540$141
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale3,140$140
Jun 17, 2026Scholl Hendrik Peter · officer: Chief Medical OfficerSale784$138
May 8, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale428$154
May 8, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale9$155
May 8, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale3$155
May 8, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale226$152
May 7, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale100$156
May 7, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale128$153
May 7, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale424$153
May 7, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale240$154
May 7, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale8$152
May 6, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale120$154
May 6, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale68$158
May 6, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale155$157
May 6, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale121$157
May 6, 2026MATA NATHAN L. · officer: Chief Scientific OfficerSale173$155
Institutional positioning

13F filings over the trailing two quarters

New 28Increased 28Reduced 15Sold out 76
FilerActionSharesFiled
DARWIN GLOBAL MANAGEMENT, LTD.Increased3,057,412May 15, 2026
PARADIGM BIOCAPITAL ADVISORS LPNew Position1,114,784May 15, 2026
UBS GROUP AGIncreased768,359May 5, 2026
RTW INVESTMENTS, LPUnchanged715,332May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased570,088May 15, 2026
HOLOCENE ADVISORS, LPIncreased494,495May 15, 2026
EVENTIDE ASSET MANAGEMENT, LLCReduced357,650May 15, 2026
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)Increased304,013May 15, 2026
PRICE T ROWE ASSOCIATES INC /MD/New Position281,805May 15, 2026
MORGAN STANLEYIncreased201,409May 15, 2026
CITADEL ADVISORS LLCIncreased186,168Sep 2, 2026
PERCEPTIVE ADVISORS LLCReduced151,979May 29, 2026
PATIENT SQUARE CAPITAL LPNew Position116,684May 15, 2026
DUQUESNE FAMILY OFFICE LLCNew Position106,100May 15, 2026
GOLDMAN SACHS GROUP INCIncreased105,509May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 14, 2026